The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies
Open accessAbstract
BACKGROUND: Globally, access to healthcare and diagnostic technologies are known to substantially impact the reported birth prevalence of congenital heart disease (CHD). Previous studies have shown marked heterogeneity between different regions, with a suggestion that CHD prevalence is rising globally, but the degree to which this reflects differences due to environmental or genetic risk factors, as opposed to improved detection, is uncertain. We performed an updated systematic review to address these issues. METHODS: Studies reporting the birth prevalence of CHD between the years 1970-2017 were identified from searches of PubMed, EMBASE, Web of Science and Google Scholar. Data on the prevalence of total CHD and 27 anatomical subtypes of CHD were collected. Data were combined using random-effect models. Subgroup and meta-regression analyses were conducted, focused on geographical regions and levels of national income. RESULTS: Two hundred and sixty studies met the inclusion criteria, encompassing 130 758 851 live births. The birth prevalence of CHD from 1970-2017 progressively increased to a maximum in the period 2010-17 of 9.410/1000 [95% CI (confidence interval) 8.602-10.253]. This represented a significant increase over the fifteen prior years (P = 0.031). The change in prevalence of mild CHD lesions (ventricular septal defect, atrial septal defect and patent ductus arteriosus) together explained 93.4% of the increased overall prevalence, consistent with a major role of improved postnatal detection of less severe lesions. In contrast the prevalence of lesions grouped together as left ventricular outflow tract obstruction (which includes hypoplastic left heart syndrome) decreased from 0.689/1000 (95% CI 0.607-0.776) in 1995-99, to 0.475/1000 (95% CI 0.392-0.565; P = 0.004) in 2010-17, which would be consistent with improved prenatal detection and consequent termination of pregnancy when these very severe lesions are discovered. There was marked heterogeneity among geographical regions, with Africa reporting the lowest prevalence [2.315/1000 (95% CI 0.429-5.696)] and Asia the highest [9.342/1000 (95% CI 8.072-10.704)]. CONCLUSIONS: The reported prevalence of CHD globally continues to increase, with evidence of severe unmet diagnostic need in Africa. The recent prevalence of CHD in Asia for the first time appears higher than in Europe and America, where disease ascertainment is likely to be near-complete, suggesting higher genetic or environmental susceptibility to CHD among Asian people.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In a subgroup analysis based on the geographic region, a surprisingly high prevalence was reported across all regions of Sub-Saharan Africa.”
From Pooled prevalence and subgroup variations of Tetralogy of Fallot among children and adolescents with congenital heart defect in Sub-Saharan Africa: A systematic review and meta-analysis (2025) · cites this paper as [10]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Globally, it accounts for 3% to 5% of all CHD cases, with an estimated incidence of 2.8 to 3.4 per 10,000 live births [2, 10].”
From Pooled prevalence and subgroup variations of Tetralogy of Fallot among children and adolescents with congenital heart defect in Sub-Saharan Africa: A systematic review and meta-analysis (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The prevalence of Tetralogy of Fallot observed was found considerably higher compared to global estimate and reports of developed countries.”
From Pooled prevalence and subgroup variations of Tetralogy of Fallot among children and adolescents with congenital heart defect in Sub-Saharan Africa: A systematic review and meta-analysis (2025) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
The incidence of congenital heart disease.
Hoffman, J. I. E., & Kaplan, S. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01886-7 · Cited by 6,099
Birth prevalence of congenital heart disease worldwide
van der Linde, D., Konings, E. E. M., Slager, M. A., Witsenburg, M., Helbing, W. A., Takkenberg, J. J. M., & Roos-Hesselink, J. W. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.025 · Cited by 3,452 · cited 6×
“A systematic review of global prevalence data since 1930 was conducted by van der Linde et al.1 in 2010, suggesting an increase in CHD prevalence from the 1930s until 1995, with stabilization between the years 1995–2009.”
BackgroundMethodInfluentialLuchini, C., Stubbs, B., Solmi, M., & Veronese, N. (2017) · World Journal of Meta-Analysis · doi:10.13105/wjma.v5.i4.80 · Cited by 977
Genetics and Genomics of Congenital Heart Disease
Zaidi, S., & Brueckner, M. (2017) · Circulation Research · doi:10.1161/circresaha.116.309140 · Cited by 565 · cited 1×
“It is known that genetic copy number variants and de novo single-nucleotide variants may account for up to 20% of CHD accompanied by extracardiac malformations and/or intellectual impairment.(21) We were unable to stratify participants in the individual studies based on these additional diagnoses.”
BackgroundDu, Y., Xu, X., Chu, M., Guo, Y., & Wang, J. (2016) · PubMed · doi:10.3978/j.issn.2072-1439.2015.11.37 · Cited by 525
Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies
Botto, L. D., Lin, A. E., Riehle‐Colarusso, T., Malik, S., & Correa, A. (2007) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20403 · Cited by 469 · cited 2×
“In the principal analyses, CHD was classified into seven phenotypic categories, following the approach of Botto et al.(7) which groups together lesions on the basis of their anatomical/developmental similarity (Supplementary Table 2, available as Supplementary data at IJE online).”
MethodMoller, A.-B., Petzold, M., Chou, D., & Say, L. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30325-x · Cited by 377
Ambient Air Pollution and Risk of Congenital Anomalies: A Systematic Review and Meta-analysis
Vrijheid, M., Martinez, D., Manzanares, S., Dadvand, P., Schembari, A., Rankin, J., & Nieuwenhuijsen, M. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002946 · Cited by 305
Congenital heart disease: current knowledge about causes and inheritance
Blue, G. M., Kirk, E. P., Sholler, G. F., Harvey, R. P., & Winlaw, D. S. (2012) · Medical Journal of Australia · doi:10.5694/mja12.10811 · Cited by 241 · cited 3×
“The studies included in the meta-analysis showed high heterogeneity, as expected, given the unknown aetiological factors for around 80% of CHDs.2 Potentially, hospitalbased studies could have provided upwardly biased estimates of prevalence compared to national registries, both of which were included in the meta-analy…”
BackgroundResultInfluential
Research works printed but not linked: 1
- 2014, World Economic Situation and Prospects
Cited by
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Global burden of heart failure: a comprehensive and updated review of epidemiology
Savarese, G., Becher, P. M., Lund, L. H., Seferovic, P., Rosano, G. M. C., & Coats, A. J. S. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvac013 · Cited by 3,315
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
2020 ESC Guidelines for the management of adult congenital heart disease
Baumgartner, H., De Backer, J., Babu-Narayan, S. V., Budts, W., Chessa, M., Diller, G.-P., lung, B., Kluin, J., Lang, I. M., Meijboom, F., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa554 · Cited by 2,311
Metadata
- Authors
- Liu, Y., Chen, S., Zühlke, L., Black, G. C., Choy, M.-K., Li, N., & Keavney, B. D.
- Affiliations
- University of Manchester (GB)
- Sichuan University (CN)
- Department of Paediatrics, Red Cross War Memorial Children’s Hospital, University of Cape Town, Cape Town, South Africa
- Manchester Academic Health Science Centre (GB)
- Corresponding author
- Keavney, Bernard D
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-02-19
- Volume
- 48
- Issue
- 2
- Pages
- 455-463
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- PMC
- PMC6469300
- OpenAlex
- W2918094628
- Cited by
- 1,436
- References
- 20
- Citations by year
- 2026: 216 · 2025: 233 · 2024: 288 · 2023: 228 · 2022: 197 · 2021: 162 · 2020: 86 · 2019: 22
- FWCI
- 17.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- International Journal of Epidemiology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- e-space (Manchester Metropolitan University) (acceptedVersion)
- Research Explorer (The University of Manchester) (submittedVersion, cc-by)
- Funders
- The British Heart Foundation
- The University of Manchester-Peking University Health Science Centre Alliance
- China Scholarships Council
- Medical Research Council
- South African Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Congenital Heart Disease Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Health Sciences › Medicine › Surgery › Congenital Anomalies and Fetal Surgery
- Keywords
- congenital heart disease, birth prevalence, temporal trends, ventricular septal defect, atrial septal defect, patent ductus arteriosus, left ventricular outflow tract obstruction, hypoplastic left heart syndrome, prenatal diagnosis, abortion, postnatal diagnosis, regional variation, national income, Africa, South America, Asia, Europe
- MeSH terms
- Heart Defects, Congenital, Humans, Infant, Newborn, Global Health, Prevalence, Confidence Intervals
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies. https://app.cochat.ai/papers/10.1093/ije/dyz009
- The paper
- Liu, Y., Chen, S., Zühlke, L., Black, G. C., Choy, M.-K., Li, N., & Keavney, B. D. (2019). Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyz009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.